Parallax Volatility Advisers
IOVA icon

Parallax Volatility Advisers’s Iovance Biotherapeutics IOVA Stock Holding History

Parallax Volatility Advisers’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,300
Closed -$34.1K – 2137
2024
Q1 		$34.1K Buy
+2,300
New +$26.8K ﹤0.01% 1656
2021
Q1 		– Sell
-1,100
Closed -$51K – 1611
2020
Q4 		$51K Sell
1,100
-100
-8% -$3.97K ﹤0.01% 2038
2020
Q3 		$40K Sell
1,200
-300
-20% -$9.2K ﹤0.01% 2880
2020
Q2 		$40K Buy
+1,500
New +$49.3K ﹤0.01% 2525

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Parallax Volatility Advisers's IOVA Position: Q1 2024 in Review

Parallax Volatility Advisers sold out of Iovance Biotherapeutics (IOVA) in Q1 2024, closing a stake of 11,977 shares — an estimated $139K sold.

Parallax Volatility Advisers first reported a position in IOVA in Q4 2017 and held it in 8 quarters. The position peaked at $301K in Q3 2020. 273 funds tracked by Wall St. Rank hold IOVA as of Q1 2024.

  • Parallax Volatility Advisers reported no remaining Iovance Biotherapeutics position as of Q1 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 11,977 Iovance Biotherapeutics shares in Q1 2024, an estimated $139K.
  • Parallax Volatility Advisers first reported a position in Iovance Biotherapeutics in Q4 2017 and held it in 8 quarters.
  • Parallax Volatility Advisers's Iovance Biotherapeutics position peaked at $301K in Q3 2020.
  • 273 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2024.

Based on Parallax Volatility Advisers's 13F filing for Q1 2024, filed 15 May 2024.